Officer Joseph Burnett Files Intent to Sell Additional $370K in Shares
CLPT has more than doubled off its 52-week low of $8.27.
Summary
ClearPoint Neuro officer and director Joseph Burnett has filed a Form 144 indicating his intent to sell 20,000 shares, valued at approximately $369,600, continuing a recent pattern of insider sales.
Key Events · Ownership and Investor Activity · CLPT
-
Officer Files Intent to Sell
Joseph Burnett, an officer and director of ClearPoint Neuro, Inc., has filed a Form 144 indicating his intent to sell 20,000 shares of common stock.
-
Proposed Sale Value
The proposed sale has an approximate market value of $369,600 based on recent trading prices.
-
Continuation of Selling Pattern
This filing follows Burnett's previous sales of 61,843 shares for over $1.1 million in the past three months, indicating a sustained pattern of insider distribution.
-
Broader Insider Distribution
The company has seen a net insider distribution of over $1.4 million in open-market sales over the last 90 days, with this filing contributing to that trend.
Analysis · CLPT · Industrial Applications And Services
This Form 144 indicates that Joseph Burnett, an officer and director, intends to sell an additional 20,000 shares. This proposed sale, valued at approximately $369,600, contributes to a broader pattern of insider distribution, as Burnett has already sold over $1.1 million in shares in the past three months. The ongoing selling by a key executive could signal a lack of conviction or a need for liquidity, potentially adding to negative sentiment.
At the time of this filing, CLPT was trading at $19.59 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $582.7M. The 52-week trading range was $8.27 to $30.10. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.